AI Assistant
Blog
Pricing
Log In
Sign Up
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experience
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
